NCT04075643View on ClinicalTrials.gov

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

September 19, 2019

Primary Completion Date

September 30, 2019

Study Completion Date

October 30, 2019

Conditions
Cardiovascular Diseases
Interventions
DRUG

Reference drug

D935 Cap. 1 Cap., single oral administration under fasting condition

DRUG

Test drug

CKD-385 Tab. 1 Tab., single oral administration under fasting condition

Trial Locations (1)

Unknown

Chonbuk National University Hospital, Jeonju

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY